Atrial fibrillation associated with increased risk of death and cardiovascular events in women

May 24, 2011 in Cardiology

Researchers at Brigham and Women's Hospital (BWH) have found that among women who are mostly healthy, those diagnosed with atrial fibrillation have an increased risk of death when compared to women without atrial fibrillation. These findings are published in the May 25, 2011 issue of the Journal of the American Medical Association.

"We knew that atrial fibrillation was associated with an increase risk of death in most cases, but in this study we found that even in a population of women who were mostly healthy and did not have established cardiovascular disease, the diagnosis of atrial fibrillation increased the incidence of death by about 2 fold," said Christine Albert, MD, a cardiac electrophysiologist at BWH and senior author of the paper. "Although the risk of death was elevated, the absolute risk of death among the women with AF in this healthy population was relatively low.

Researchers monitored more than 34,000 women participating in the Women's Health Study for approximately 15 years. The women were primarily white and over the age of 45. During that time period, 1,011 women developed atrial fibrillation. Approximately 2.1 percent of the deaths in the entire population could be attributed to the development of atrial fibrillation. Researchers also found that women with atrial fibrillation experienced a higher risk of cardiovascular events such as heart attack, stroke and . In fact, much of the elevation in risk of death could be explained by the development of these potentially preventable and treatable medical conditions.

"Some of these deaths may be preventable through available therapies including and . What this means for women with atrial fibrillation is that it is very important to optimally manage risk factors for cardiovascular disease with the help of their physician. However, there is also a portion of this increased risk that persists even when these are taken into account. For this reason, more research is needed to further understand the causes of atrial fibrillation so that we might identify ways to prevent atrial fibrillation and death associated with it." Albert said.

More information: JAMA. 2011;305[20]2080-2087.

Provided by Brigham and Women's Hospital

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 2 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 21 hours ago | popularity 5 / 5 (1) | comments 0


Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...

Researchers analyse hunting behaviour of fish larvae in virtual reality

Moving objects attract greater attention – a fact exploited by video screens in public spaces and animated advertising banners on the Internet. For most animal species, moving objects also play a major ...

Overeating learned in infancy, study suggests

In the long run, encouraging a baby to finish the last ounce in their bottle might be doing more harm than good.

Study details genes that control whether tumors adapt or die when faced with p53 activating drugs

When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...

Children of married parents less likely to be obese

Children living in households where the parents are married are less likely to be obese, according to new research from Rice University and the University of Houston.